Background: The roles of microphthalmia-associated transcription factor (Mitf) in the skeletal muscle and during myogenesis are unclear.
Introduction
Skeletal muscle formation consists of a complex set of differentiation steps: commitment of mesenchymal stem cells to myoblast lineage cells, progression of differentiation with the expression of muscle-cell-specific proteins, and fusion of myoblasts into multinucleated myotubes. Mammalian myotube formation occurs in two phases [1, 2] . In the first phase, differentiated myoblasts fuse together to form small myotubes; to accomplish this process, proliferating myoblasts exit cell cycle, and some myoblasts undergo apoptosis. In the second phase, additional myoblasts subsequently fuse with myotubes to form large myotubes. Although the roles of myogenic regulatory factors (MRFs), including Myf5, Myod, Myogenin and Mrf4, in myogenic differentiation are unquestionable [3] [4] [5] , a number of factors, such as secreted proteins, membrane proteins and transcriptional regulators, are also involved in myogenesis [2] .
Microphthalmia-associated transcription factor (Mitf) is a member of the basic helix-loop-helix leucine zipper (bHLH-LZ) family of transcription factors [6] [7] [8] .
Expression levels of Mitf, evaluated by Western blotting and Northern blotting, vary among tissues; it is highly expressed in melanocytes, mast cells, osteoclasts, and the heart [9] [10] [11] . Thus, the roles of Mitf have been mainly examined in these cells [11] [12] [13] [14] , and Mitf activities in other tissues are largely unknown. Of the Mitf variants that are not the result of genetic mutation, nine Mitf isoforms have been identified in mice that differ in their transcriptional initiation site: Mitf-A, -B, -C, -D, -E, -H, -J, -M and -mc. The Mitf variants contain an isoform-specific first exon, while exons 2 to 9 of all Mitf isoforms examined to date are identical. Mitf isoforms are expressed in a cell type-specific manner, and their transcriptional activities are slightly but significantly different depending on the target gene [15] [16] [17] [18] [19] . In addition, two types of Mitf mRNAs with or without an 18-base insert (exon 6a) are generated by alternative use of the two acceptor sites located at the 5' end of exon 6 in Mitf-A, -H, -J, -M and -mc [6, 9, 20, 21] . In the present study, we show the relatively higher expression of Mitf-A in the skeletal muscle, and present the potential role of Mitf in the progression of myogenesis.
Materials and methods
Animals and cell culture Nine C57BL/6 mice aged 7-8 wk were used to examine the tissue distribution of Mitf.
The experiment was approved by Azabu University Animal Experiment Committee.
C2C12 myoblasts were obtained from the American Type Culture Collection (Rockville, MD). Cells were cultured in growth medium, i.e., Dulbecco's modified Eagle's medium (DMEM) with heat-inactivated 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 g/ml streptomycin, at 37°C under a humidified 5% CO 2 atmosphere. To induce differentiation from myoblasts to myotubes, the medium was replaced at confluence (day 0) with differentiation medium consisting of DMEM with 2% horse serum supplementing the antibiotics. To isolate myotubes, cells on day 7 were trypsinized for a short time under a microscope until detachment of multinucleated cells (2 min), followed by centrifugation to obtain a myotube-rich fraction.
RT-PCR, restriction fragment length polymorphism and quantitative RT-PCR
Total RNA isolation from tissues and cells, RT-PCR and restriction fragment length polymorphism (RFLP) were performed as described previously [21] . Quantitative RT-PCR (qRT-PCR) was carried out as described previously [22] . The used PCR primers in qRT-PCR are presented in Table 1 . To compare tissue Mitf expression, the appropriate corrected gene was chosen using a mouse housekeeping gene primer set (TaKaRa, Otsu, Japan). The relative mRNA level was expressed as a ratio with -actin to evaluate tissue distribution and Gapdh was used as a reference gene to examine regulatory expression in C2C12 cells.
Western blotting
To examine expression of Mitf in the skeletal muscle, thigh muscle and heart as a positive control were homogenized in RIPA buffer. After 30 min on ice, the debris was removed by centrifugation at 2,500 × g for 2 min at 4ºC. After centrifugation at 12,000 × g for 5 min at 4ºC, the supernatant was recovered and the protein concentration was measured by the bicinchoninic acid method [23] . Fifty g of the protein was loaded on 10% SDS-polyacrylamide gel. Western blotting was performed as described previously [24, 25] . Expression of Mitf and myosin heavy chain (Myhc) was examined by use of mouse monoclonal antibodies against Mitf (X1405M; Exalpha Biologicals) and Myhc (MY-32; Sigma), respectively. There are two types of muscle fiber, i.e., fast-twitch and slow-twitch; fast-twitch muscle fibers express Myhc2a, Myhc2b and Myhc2x, whreas slow-twitch muscle fibers do Myhc1 [26] . According to the manufacturer's manual, this antibody for Myhc recognizes fast-type muscle fibers.
After incubation of the membranes with ECL Advance reagent (GE Healthcare), the chemiluminescent signals were exposed to X-ray film. Subsequently, antibodies as well as the detection reagents were stripped and reprobed with anti--tubulin (ab11304; Abcam) or anti--actin antibody (AC-15; Abcam).
Immunohistochemistry
C2C12 cells were grown on glass chamber slides coated with type I collagen (Thermo Fisher Scientific) and were fixed with 3% paraformaldehyde in PBS for 30 min, followed by treatment with 1% Triton X-100 in PBS for 10 min. After washing with PBS, cells were incubated with 3% H 2 O 2 to remove endogenous peroxidase.
Subsequently, cells were treated with 1.5% normal goat serum in PBS for 20 min to block nonspecific reactions. Diluted mouse monoclonal antibody against Mitf (X1405M; Exalpha Biologicals) with 0.1% bovine serum albumin in PBS at 1 : 80 was used to identify Mitf expression at the protein level. After incubation with the primary antibody for 2 h at room temperature, Mitf-positive cells were visualized using VECTASTAIN Elite ABC kit (Vector Laboratories) and 3,3'-diaminobenzidine (DAB; Dojindo) according to the manufacturer's protocol.
siRNA transfection
To target the expression of common Mitf, Mitf-A or Itga9 and green fluorescent protein (GFP) controls, oligonucleotides for the respective genes were synthesized by BONAC corporation (Kurume, Japan) as follows: 5'-GAAACUUGAUCGACCUCUACA-3' and 
Morphological analysis
Cells were fixed with methanol for 2 min and subsequently stained with Giemsa staining for 20 min. Cells with more than 3 nuclei were judged as myotubes. Eight views per treatment in an experiment were analyzed. Experiments were repeated two or three times, and similar results were obtained.
BrdU incorporation
Proliferation of C2C12 cells was measured by a BrdU cell proliferation assay (Cell Proliferation ELISA, BrdU (colorimetric); Roche) according to the manufacturer's protocol.
Statistical analysis
Data are presented as the mean  SE. Comparisons between groups were conducted using Student's t-test. Results were considered significant at P < 0.05.
Results

Expression of Mitf in tissues and during myogenesis
Tissue distribution of Mitf was quantified by qRT-PCR. First, the expressions of 12 genes, Atp5f1, B2m, -actin, Gapdh, Hprt1, Pgk1, Ppia, RpLp1, Rps18, Tbp, Tfrc, and Ywhaz, were quantified for evaluation as appropriate corrected genes; quantitative PCR using cDNA prepared from equal amounts of total RNA revealed that -actin expression was the most stable among the tested tissues, which were evaluated by "geNorm" (http://medgen.ugent.be/~jvdesomp/genorm/) (data not shown). Thus, the gene transcript level of Mitf was corrected for that of -actin ( Fig. 1A) .
Expression of
Mitf was highest in the heart, as expected. Although Mitf is recognized as a tissue-restricted transcription factor [6] [7] [8] , its expression was detected in a wide variety of tissues. In particular, expression in the skeletal muscle was relatively higher.
Previous studies indicated Mitf expression in the skeletal muscle [9, 27] , but the role of Mitf is not known. Thus, we characterized the expression and function of Mitf in the skeletal muscle and during myogenesis in detail. Examining Mitf isoforms differing in transcriptional initiation site in the skeletal muscle indicated that more than 99% of Mitf was Mitf-A, and that Mitf-H and -J were also expressed significantly ( Fig. 1B) .
In a C2C12 myotube differentiation model, C2C12 myoblasts fuse to form multinucleated myotube cells upon serum starvation on day 0 [28] . To evaluate gene expression in C2C12 cells, we chose Gapdh instead of -actin as a reference gene;
qPCR using cDNA prepared from equal amount of total RNA indicated gradual decrease in -actin expression with progression of myogenesis, whereas expression of Western blot analyses ( Fig. 1D ). In addition, consistent with the changes at the mRNA level, expression of Mitf protein was increased after differentiation stimulation ( Fig. 1E ).
Furthermore, Mitf was exclusively localized in the nucleus of C2C12 cells ( Fig. 1F ).
We also examined the ratio of gene transcripts of Mitf with exon 6a to that of Mitf without exon 6a by PCR-RFLP analyses; the ratios of Mitf-A and Mitf-J were relatively constant during myogenesis ( Fig. 1G ).
Disruption of Mitf expression inhibits myotube formation by blocking increased expression of p21 and Itga9 induction
To clarify the roles of Mitf in myogenesis, we evaluated effects of decreased expression of Mitf, which was achieved by transfection with siRNA for Mitf ( Supplementary Fig.   2A , lanes 2 and 3, and B). Transfection of siRNA for common Mitf effectively decreased the emergence of multinucleated myotubes on day 6, as compared with GFP ( Fig. 2A ). Knockdown of Mitf-A also blocked the formation of thick myotubes ( Fig. 2B , Supplementary Fig. 2C ). Morphological analyses on day 6 indicated that the number of multinucleated cells, which were defined as cells with more than 3 nuclei, was significantly decreased by transfection of siRNA for Mitf (Fig. 2C ). We also evaluated the differentiated myotubes in detail; knockdown of Mitf increased the proportion of myotubes with 3 to 5 nuclei, but decreased that of myotubes with more than 6 nuclei ( Fig. 2D ). Similar results were also obtained in C2C12 cells transfected with siRNA for
Mitf-A ( Supplementary Fig. 3 ). Furthermore, Mitf knockdown decreased the expression of Myhc, a myotube-specific protein [3] [4] [5] , in C2C12 cells on day 8 ( Fig. 2E, lanes 1 and 2). These results suggest that Mitf is required not only for myoblast-myoblast fusion but also for maturation of nascent myotubes. We also examined effects of forced Mitf expression on myotube formation; the expression did not enhance myogenesis (data not shown). Other than MRFs, several molecules related to cell attachment and fusion, such as
Molecular bases of decreased myotube formation by
and v-Cam1 are known to regulate myotube differentiation [2, [31] [32] [33] [34] . In addition, the cDNA microarray database (http://www.ncbi.nlm.nih.gov/geo/) indicated that the expressions of Ccna2, Itga5, p21, p57, Ptger4, Rb1, and Vcl increased with differentiation. In view of Mitf as a transcription factor, we expected that Mitf is involved in myogenesis through transcriptional activation of these myogenesis-regulating genes. Thus, the effects of decrease in Mitf expression on the expression level of these genes were explored. We found that gene transcript levels of p21 and Itga9 after differentiation stimulation were decreased by transfection of siRNA for common Mitf; expression of p21 was increased in response to differentiation stimulation, and Mitf knockdown blocked the increased expression of p21 (Fig. 3E ).
Significant expression of Itga9 was detected after day 4, and the expression level was decreased by transfection of siRNA for Mitf (Fig. 3F ). Decreased expression of p21 and
Itga9 was also detected in Mitf-A-knockdown cells ( Supplementary Fig. 4 ). Gene transcript levels of the other genes were unaffected by Mitf knockdown ( Supplementary   Fig. 5 ).
In a C2C12 myogenesis cell model, not all myoblasts not fuse into myotubes;
co-existence of proliferating myoblasts and myotubes is detected after differentiation stimulation [35] [36] [37] . We separated the myotube-rich fraction by limited trypsinization to explore cells affected by Mitf knockdown. Although Myhc2a expression was not significantly different between the myotube fraction and the residual cell fraction in control cells (Fig. 4A ), Myhc2b and Myhc2x were predominantly expressed in the myotube fraction as expected ( Fig. 4B and C). Expression of Myhc2x in the myotube fraction was significantly lower in Mitf-knockdown cells than in control cells, whereas that of Myhc2a in the myotube fraction was higher in the Mitf-knockdown cells. The
Myhc2b expression in the myotube fraction was comparable between in control cells and in Mitf-knockdown cells. Considering that Myhc2x was the major isoform of type 2
Myhc (> 93%) ( Fig. 4D ), total expression of Myhc constituting of fast-twitch myofibers was largely limited to the myotube fraction, and was decreased by Mitf knockdown; the latter was consistent with the results on Myhc expression at the protein level ( Fig. 2E ).
The extent of the decreased expression of Mitf resulting from knockdown of Mitf was comparable between the myotube fraction and the residual cell fraction, indicating effective inhibition of Mitf expression in both myoblasts and myotubes ( Fig. 5A ).
Expression of p21 was significantly higher in the myotube fraction than in the residual cell fraction (Fig. 5B ). Knockdown of Mitf equally decreased the expression of between the two fractions. Expression of Itga9 was also significantly higher in the myotube fraction ( Fig. 5C ). Similar to the expression of p21, Mitf knockdown down-regulated the expression of Itga9 in both fractions.
Cell cycle exit in response to differentiation stimulation is a prerequisite for myotube formation [2] ; p21, a cyclin-dependent kinase inhibitor inducing cell cycle exit, plays a role in post-mitotic myogenesis, although it also maintains anti-apoptotic states in differentiated myocytes [1] . To link the decreased Mitf-induced inhibition of myotube formation and blockage of p21 induction, effects of the decreased Mitf expression on BrdU uptake were next examined; BrdU uptake was significantly increased by transfection of siRNA for Mitf on day 4-6 ( Fig. 5A ). Knockdown of p21, however, did not affect BrdU uptake (Fig. 5B ). Similar to Mitf knockdown, decreased expression of p21 inhibited emergence of maturated and thick myotubes ( Fig. 5C ). In addition, it significantly decreased the number of multinucleated cells (Fig. 5D ), and increased and decreased the proportion of myotubes with 3 to 5 nuclei and those with more than 6 nuclei, respectively (Fig. 5E ).
We next explored the effects of Itga9 knockdown on myotube formation. The morphology of cells transfected with siRNA for Itga9 indicated that, compared to control cells, thinner myotubes were evident by Itga9 knockdown, suggesting that Itga9 is required for myotube maturation (Fig. 6A) , which was verified by morphometry. The multinucleated cell number itself was not affected by knockdown of Itga9 (Fig. 6B ), but the proportion of the number of myotubes with 3-5 nuclei in a cell to that of total myotubes was significantly increased, and that with more than 6 nuclei was decreased ( Fig. 6C) . Consistent with the results, knockdown of Itga9 gene resulted in the decreased expression of Myhc ( Fig. 2E, lanes 1 and 3) .
Discussion
Here, we demonstrate that 1) A isoform of Mitf mRNA is abundant in the skeletal A target gene of Mitf was Itga9. Among members of the integrin family, Itga3, 4, 6 and 9 have been suggested to regulate myogenesis [2, 31, 33, 34] . Transcription of Itga4 was activated through Mitf binding to the E-box located in the 5'-untranslated region in mast cells [38] . In the present study, however, Itga4 mRNA was not decreased but rather increased by transfection of siRNA for Mitf in C2C12 cells ( Supplementary Fig.   2H ), suggesting that transcription by Mitf is regulated in a cell context-dependent manner. In addition, Mitf knockdown did not affect the expression level of Itga3 and 6 ( Supplementary Fig. 2G and J) . In a study using a human mononucleated myogenic precursor cell culture system, addition of anti-INTEGRIN 91 antibody to the culture medium decreased the proportion of nuclei included in large myotubes (≥5 nuclei),
whereas the proportion of nuclei incorporated in small myotubes (2-4 nuclei) was unchanged [33] . In the present study using a murine myogenesis model, transfection with siRNA for Itga9 decreased the proportion of large myotubes (6 nuclei) and increased that of small myotubes (3-5 nuclei), but did not affect the number of multinucleated cells. Taking these results together, Itga9 is suggested to promote the growth of preformed myotubes rather than the formation of nascent myotubes during myogenesis.
Effects of knockdown of Mitf mRNA partly overlapped but were distinct from those of Itga9 knockdown; the number of multinucleated cells was decreased by Mitf knockdown. This suggests that Mitf is involved in both myoblast-myoblast fusion and subsequent maturation of nascent myotubes. It is possible that Mitf regulates myoblast-myoblast fusion through the increase in p21 expression; regulatory expression of p21 by Mitf has also been shown in melanocytes [39] . Cell cycle inhibition and apoptosis of myoblasts precede to myoblast-myoblast fusion, and both processes are necessary for the cell fusion [1] . p21 is principally involved as a molecule to establish post-mitotic and apoptosis-resistant states [1] ; BrdU uptake was not detected in p21-positive myoblasts [40] , and forced expression of p21 but not inactive p21 inhibited apoptosis of C2C12 myoblasts [41] . In fact, p21 knockdown decreased the myotube number and increased proportion of small myotubes, suggesting that p21 expression is required for efficient myoblast-myoblast fusion.
Knockdown of p21 did not increase BrdU uptake on day 4 and 6; it may be offset Mitf encoded by the mutant mi allele deletes one of four consecutive arginines in the basic domain, and acts as a dominant-negative mutant [9, 27, 42] . The mi/mi mutant mice exhibited the pleiotropic effects of microphthalmia, depletion of pigment in both hair and eyes, and osteopetrosis resulting from defects of osteoclastogenesis [9, 14] . In addition to these phenotype alterations, Katayama et al. [43] recently showed that masseter muscle development was disrupted in mi/mi mutant mice; they speculated that the disorder is a secondary event related to abnormal tooth formation related to 
